Product Information

OXCARBAZEPINE ER 150 MG TABLET is a generic product labeled by Apotex Corp., priced at $3.3733 per EA under NDC 60505412807. Its NADAC has been published 88 times since Dec 18, 2024.

FDA first approved this application on Jul 13, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the OXCARBAZEPINE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for OXCARBAZEPINE ER 150 MG TABLET has been published 88 times since Dec 18, 2024, and over the history we have for it it has declined 46.2%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 97% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.